Heart retransplant recipients have better survival with concurrent kidney transplant than with heart retransplant alone

Jill Savla, Kimberly Y. Lin, Madhura Pradhan, Rebecca Ruebner, Rachel S. Rogers, Somaly S. Haskins, Anjali T. Owens, Peter Abt, J. William Gaynor, Robert E. Shaddy, Joseph W. Rossano

Research output: Contribution to journalArticle

Abstract

Background-Heart retransplant (HRT) recipients represent a growing number of transplant patients. The impact of concurrent kidney transplants (KTs) in this population has not been well studied. We tested the hypothesis that recipients of HRT with concurrent KT (HRT-KT) would have worse survival than recipients of HRT alone. Methods and Results-A retrospective analysis of the United Network of Organ Sharing database was performed for all patients undergoing HRT from 1987 to 2011. There were 1660 HRT patients, of which 116 (7%) received concurrent KT. Those who received HRT-KT had older age, longer wait-list time, worse kidney function, and more known diabetes. Survival among recipients of HRT-KT was significantly better than that of recipients of HRT alone (P=0.005). A subgroup of 323 HRT patients with severe kidney dysfunction (estimated glomerular filtration rate < 30 mL/min per 1.73 m2 or on dialysis) was studied in more detail, and 76 (24%) received concurrent KT. Those on dialysis at the time of HRT had better survival with versus without concurrent KT (P < 0.0001). On multivariable analysis, concurrent KT was independently associated with better outcomes for all patients with HRT and for the subgroup of patients with severe kidney dysfunction. Conclusions-Recipients of HRT-KT have better survival than recipients of HRT alone. Further research is needed to determine which HRT patients may benefit the most from concurrent KT.

Original languageEnglish (US)
Article numbere002435
JournalJournal of the American Heart Association
Volume4
Issue number12
DOIs
StatePublished - Dec 1 2015
Externally publishedYes

Fingerprint

Transplants
Kidney
Survival
Dialysis
Glomerular Filtration Rate
Databases

Keywords

  • Heart
  • Kidney
  • Survival
  • Transplantation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Heart retransplant recipients have better survival with concurrent kidney transplant than with heart retransplant alone. / Savla, Jill; Lin, Kimberly Y.; Pradhan, Madhura; Ruebner, Rebecca; Rogers, Rachel S.; Haskins, Somaly S.; Owens, Anjali T.; Abt, Peter; Gaynor, J. William; Shaddy, Robert E.; Rossano, Joseph W.

In: Journal of the American Heart Association, Vol. 4, No. 12, e002435, 01.12.2015.

Research output: Contribution to journalArticle

Savla, J, Lin, KY, Pradhan, M, Ruebner, R, Rogers, RS, Haskins, SS, Owens, AT, Abt, P, Gaynor, JW, Shaddy, RE & Rossano, JW 2015, 'Heart retransplant recipients have better survival with concurrent kidney transplant than with heart retransplant alone', Journal of the American Heart Association, vol. 4, no. 12, e002435. https://doi.org/10.1161/JAHA.115.002435
Savla, Jill ; Lin, Kimberly Y. ; Pradhan, Madhura ; Ruebner, Rebecca ; Rogers, Rachel S. ; Haskins, Somaly S. ; Owens, Anjali T. ; Abt, Peter ; Gaynor, J. William ; Shaddy, Robert E. ; Rossano, Joseph W. / Heart retransplant recipients have better survival with concurrent kidney transplant than with heart retransplant alone. In: Journal of the American Heart Association. 2015 ; Vol. 4, No. 12.
@article{93cb52361d3b4cc08d970ba57bcd1a05,
title = "Heart retransplant recipients have better survival with concurrent kidney transplant than with heart retransplant alone",
abstract = "Background-Heart retransplant (HRT) recipients represent a growing number of transplant patients. The impact of concurrent kidney transplants (KTs) in this population has not been well studied. We tested the hypothesis that recipients of HRT with concurrent KT (HRT-KT) would have worse survival than recipients of HRT alone. Methods and Results-A retrospective analysis of the United Network of Organ Sharing database was performed for all patients undergoing HRT from 1987 to 2011. There were 1660 HRT patients, of which 116 (7{\%}) received concurrent KT. Those who received HRT-KT had older age, longer wait-list time, worse kidney function, and more known diabetes. Survival among recipients of HRT-KT was significantly better than that of recipients of HRT alone (P=0.005). A subgroup of 323 HRT patients with severe kidney dysfunction (estimated glomerular filtration rate < 30 mL/min per 1.73 m2 or on dialysis) was studied in more detail, and 76 (24{\%}) received concurrent KT. Those on dialysis at the time of HRT had better survival with versus without concurrent KT (P < 0.0001). On multivariable analysis, concurrent KT was independently associated with better outcomes for all patients with HRT and for the subgroup of patients with severe kidney dysfunction. Conclusions-Recipients of HRT-KT have better survival than recipients of HRT alone. Further research is needed to determine which HRT patients may benefit the most from concurrent KT.",
keywords = "Heart, Kidney, Survival, Transplantation",
author = "Jill Savla and Lin, {Kimberly Y.} and Madhura Pradhan and Rebecca Ruebner and Rogers, {Rachel S.} and Haskins, {Somaly S.} and Owens, {Anjali T.} and Peter Abt and Gaynor, {J. William} and Shaddy, {Robert E.} and Rossano, {Joseph W.}",
year = "2015",
month = "12",
day = "1",
doi = "10.1161/JAHA.115.002435",
language = "English (US)",
volume = "4",
journal = "Journal of the American Heart Association",
issn = "2047-9980",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Heart retransplant recipients have better survival with concurrent kidney transplant than with heart retransplant alone

AU - Savla, Jill

AU - Lin, Kimberly Y.

AU - Pradhan, Madhura

AU - Ruebner, Rebecca

AU - Rogers, Rachel S.

AU - Haskins, Somaly S.

AU - Owens, Anjali T.

AU - Abt, Peter

AU - Gaynor, J. William

AU - Shaddy, Robert E.

AU - Rossano, Joseph W.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Background-Heart retransplant (HRT) recipients represent a growing number of transplant patients. The impact of concurrent kidney transplants (KTs) in this population has not been well studied. We tested the hypothesis that recipients of HRT with concurrent KT (HRT-KT) would have worse survival than recipients of HRT alone. Methods and Results-A retrospective analysis of the United Network of Organ Sharing database was performed for all patients undergoing HRT from 1987 to 2011. There were 1660 HRT patients, of which 116 (7%) received concurrent KT. Those who received HRT-KT had older age, longer wait-list time, worse kidney function, and more known diabetes. Survival among recipients of HRT-KT was significantly better than that of recipients of HRT alone (P=0.005). A subgroup of 323 HRT patients with severe kidney dysfunction (estimated glomerular filtration rate < 30 mL/min per 1.73 m2 or on dialysis) was studied in more detail, and 76 (24%) received concurrent KT. Those on dialysis at the time of HRT had better survival with versus without concurrent KT (P < 0.0001). On multivariable analysis, concurrent KT was independently associated with better outcomes for all patients with HRT and for the subgroup of patients with severe kidney dysfunction. Conclusions-Recipients of HRT-KT have better survival than recipients of HRT alone. Further research is needed to determine which HRT patients may benefit the most from concurrent KT.

AB - Background-Heart retransplant (HRT) recipients represent a growing number of transplant patients. The impact of concurrent kidney transplants (KTs) in this population has not been well studied. We tested the hypothesis that recipients of HRT with concurrent KT (HRT-KT) would have worse survival than recipients of HRT alone. Methods and Results-A retrospective analysis of the United Network of Organ Sharing database was performed for all patients undergoing HRT from 1987 to 2011. There were 1660 HRT patients, of which 116 (7%) received concurrent KT. Those who received HRT-KT had older age, longer wait-list time, worse kidney function, and more known diabetes. Survival among recipients of HRT-KT was significantly better than that of recipients of HRT alone (P=0.005). A subgroup of 323 HRT patients with severe kidney dysfunction (estimated glomerular filtration rate < 30 mL/min per 1.73 m2 or on dialysis) was studied in more detail, and 76 (24%) received concurrent KT. Those on dialysis at the time of HRT had better survival with versus without concurrent KT (P < 0.0001). On multivariable analysis, concurrent KT was independently associated with better outcomes for all patients with HRT and for the subgroup of patients with severe kidney dysfunction. Conclusions-Recipients of HRT-KT have better survival than recipients of HRT alone. Further research is needed to determine which HRT patients may benefit the most from concurrent KT.

KW - Heart

KW - Kidney

KW - Survival

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=85006208840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006208840&partnerID=8YFLogxK

U2 - 10.1161/JAHA.115.002435

DO - 10.1161/JAHA.115.002435

M3 - Article

C2 - 26656863

AN - SCOPUS:85006208840

VL - 4

JO - Journal of the American Heart Association

JF - Journal of the American Heart Association

SN - 2047-9980

IS - 12

M1 - e002435

ER -